Top 5 Biotechnology VC (Venture Capital) Funds in Lithuania in July 2025

Last updated: Jul 2025 A list of 5 VC (Venture Capital) funds that invest in Biotechnology startups based in Lithuania. We rank investors based on the number of investments they made in Biotechnology companies from Lithuania. We update this investor list every month.

Top 5 Biotechnology VC (Venture Capital) Funds in Lithuania in July 2025

Investor	Biotechnology Lithuania investments
Practica Capital	5
Metaplanet	3
Vsquared Ventures	2
Kilo Health	1
UVC Partners	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

Practica Capital

Investment focus

B2B, Software, Information Technology
Seed, Funding Round, Series A
Lithuania, United Kingdom, United States

Portfolio highlights

AMLYZE — AMLYZE Risk Assessment Module is an automated customer AML/CFT Risk Assessment and Management feature for financial companies.
Qminder — Set up Qminder queue management software in minutes. Real-time reports on customer service & employee performance. Cloud-based. Wireless. Free Support.
Atrandi Biosciences — Achieve your discoveries easier using high-throughput screening and droplet microfluidics. Create your own custom workflows for any R&D or academic applications.

an early-stage investment firm making long-term bets on contrarians and leveraging the knowledge and network across sectors. We back mission-driven founders working on positively disruptive deep technologies.

Investment focus

Artificial Intelligence, Software, Machine Learning
Seed, Series A, Series B
United States, United Kingdom, Estonia

Portfolio highlights

Aerones — Robotic wind turbine service company offering maintenance, inspection and repairs worldwide. Reduce downtime and improve the efficiency of your wind park
Parallel Bio — Using the immune system to cure disease. Parallel Bio uses a human immune system in a dish and AI to discover drugs more likely to work in patients.
Atrandi Biosciences — Achieve your discoveries easier using high-throughput screening and droplet microfluidics. Create your own custom workflows for any R&D or academic applications.

Vsquared Ventures invests in early-stage deep-tech companies that are tackling society's most pressing challenges, with a focus on quantum and novel computing, green energy, robotics, AI/ML, new space, synthetic biology, and healthcare. It is committed to a partnership and will go to any length to help accelerate and scale vision,unlocking all seemingly impossible possibilities.

Investment focus

Artificial Intelligence, Semiconductor, Manufacturing
Seed, Series A, Funding Round
Germany, United States, Switzerland

Portfolio highlights

Lendurai — Lendurai enables drones to operate without GNSS using computer vision and AI. Providing autonomous navigation solutions for defence and public sector UAVs.
Arlequin AI — Unlock actionable insights from complex social data to drive strategic decisions using our AI models.
Snowcap Compute — Snowcap Compute develops advanced artificial intelligence computing chips that leverage superconducting technology for faster processing and greater energy efficiency.

Kilo Health is the second fastest-growing company in Europe that works in digital health and wellness. It has 5+ million customers worldwide.

Investment focus

Apps, Health Care, Mobile Apps
Pre-Seed
Lithuania

Portfolio highlights

Tyler Health — Tyler enables anyone to discover how their nutrition and lifestyle choices can improve every aspect of their metabolic health. Intelligently using a vast database from a continuous glucose monitor (CGM), we are helping users to improve their diet, exercise, and daily performance by measuring biomarkers in real-time.

UVC Partners is a Munich- and Berlin-based early-stage venture capital firm that invests in technology-based startups in the areas of enterprise software, industrial technologies, and mobility. The fund typically invests between € 0.5 - 10m initially and up to € 20m in total per company.